Chester County News and Community Website
WASHINGTON, D.C. — According to a report published this week in JAMA, “Trends in Prevalence of Type 1 and Type 2 Diabetes in Children and Adolescents in the United States, …
Read More
MALVERN, PA — LifeScan and Cecelia Health announced the addition of a fully integrated live telehealth service with the OneTouch Reveal® app.
Read More
MALVERN, PA — LifeScan, a world leader in blood glucose monitoring serving more than 20 million people with diabetes, and Fitbit, this week announced a collaboration to offer people with …
Read More
CHESTER SPRINGS, PA — Affinity Bio Partners announced that it launched a clinical study in Pennsylvania for medical cannabis patients suffering from diabetic nerve pain.
Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration approved the first interchangeable biosimilar insulin product, indicated to improve glycemic control in adults and pediatric patients with Type 1 diabetes …
Read More MALVERN, PA — LifeScan and Noom, a digital health platform, announced a newly expanded partnership that will empower people with diabetes to take control of their health with Noom’s Diabetes …
Read More
WASHINGTON, D.C. — The following quote is attributed to Jeff Shuren, M.D., J.D., director of FDA’s Center for Devices and Radiological Health:
Read More
MALVERN, PA — LifeScan, a world leader in blood glucose monitoring, serving 20 million people with diabetes and their caregivers and the maker of the iconic OneTouch® brand products, today announced the …
Read More
The Centers for Disease and Control and Prevention (CDC) has expanded the U.S. Diabetes Surveillance System with a new social determinants of health (SDOH) module to help identify under-resourced areas …
Read More
MALVERN, PA — LifeScan, a world leader in blood glucose monitoring serving 20 million people with diabetes and the maker of the iconic OneTouch® brand, recently announced its partnership with Truepill™, …
Read More